Schön Klinik Berchtesgadener Land
Schönau am Königssee, Bavaria, 83483, Germany
NCT Number: NCT01903772
The additional effect of inspiratory muscle training as an adjunct to a general exercise training program in patients with COPD with inspiratory muscle weakness will be studied. The main hypothesis is that inspiratory muscle training combined with an exercise training program improves functional exercise capacity more than an exercise training program without the addition of an inspiratory muscle training program.
Looking for future studies?
Notify Me40 year–90 year
All sexes
Interventional
Not applicable
Schönau am Königssee, Bavaria, 83483, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program
Time frame: change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program
Time frame: change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program
Time frame: change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program
Time frame: change from the beginning at 3 weeks of a inpatient pulmonary rehabilitation program
measured via Borg-scale at rest, during 6-minute walking distance, during constant work rate test at iso-time, during inspiratory muscle endurance capacity test
Schön Klinik Berchtesgadener Land
Other
Acronym: IMTCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03240640
COPD, Chronic Disease
Leuven, Belgium
View Trial DetailsNCT01397396
COPD, Chronic Disease
Leuven, Belgium
View Trial DetailsNCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial Details